Open access · CC-BY
via OpenAlex
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets
Gerald Yu Liao, Jenna J Klug, Swastik Singh, Elizabeth Bae, Sherwin Dai, Warren Ladiges
Scientific Reports · 2026 · ▲ 2 citations
Abstract
The house cricket ( Acheta domesticus ) is a promising geroscience model due to its short lifespan, age-associated functional decline, and responsiveness to geroprotective drugs. Continuous mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), acarbose, and phenylbutyrate extends lifespan, but short-term effects remain unknown. We tested 274 sex-matched crickets given each drug for two weeks starting at 8-weeks (mid-age), with testing at 10-weeks (older adult) for olfactory discrimination, exploration, and treadmill performance. Locomotor gaits were identified by K-means clustering (silhouette > 0.5) and survival by Kaplan–Meier analysis. Olfactory discrimination was preserved in all medicated males and rapamycin-treated females versus controls ( d ’s = 1.38–1.61, P ’s < 0.01). Rapamycin restored male locomotor performance, with distance and speed exceeding controls and adults while comparable to juveniles, and maintained juvenile-like walking-to-running ratios. Rapamycin increased central exploration and freezing, whereas acarbose and phenylbutyrate increased peripheral freezing. Rapamycin and phenylbutyrate extended running time, while acarbose increased male jumping distance. Rapamycin prolonged survival in both sexes ( HR ’s = 0.40–0.48, P ’s < 0.05), whereas acarbose reduced female survival ( HR = 3.03, P = 0.01). Short-term rapamycin preserved survival, cognition, and locomotion, while acarbose and phenylbutyrate produced selective benefits, supporting A. domesticus as a scalable model for geroprotective drug discovery.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-026-68622-3
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Liao, G.Y., Klug, J.J., Singh, S., Bae, E., Dai, S., & Ladiges, W. (2026). The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-026-68622-3
Vancouver
Liao GY, Klug JJ, Singh S, Bae E, Dai S, Ladiges W. The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets. Scientific Reports. 2026. doi:10.1038/s41598-026-68622-3.
BibTeX
@article{gerald2026Theger,
title = {The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets},
author = {Gerald Yu Liao and Jenna J Klug and Swastik Singh and Elizabeth Bae and Sherwin Dai and Warren Ladiges},
journal = {Scientific Reports},
year = {2026},
doi = {10.1038/s41598-026-68622-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2025
Preprint
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets
2026
Preprint
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets
Innovation in Aging 2025
Open access · CC-BY
The house cricket (Acheta domesticus) as a scalable invertebrate model for gerotherapeutic testing
Research Square 2026
Preprint · CC-BY
The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets
ResearchWorks at the University of Washington (University of Washington) 2025
Preprint · CC-BY
The domestic house cricket as a versatile model for functional aging and therapeutic testing
Nature Aging 2022
Open access · CC-BY